Servais, Laurent http://orcid.org/0000-0001-9270-4061
Eggenspieler, Damien
Poleur, Margaux
Grelet, Marc
Muntoni, Francesco
Strijbos, Paul
Annoussamy, Mélanie
Funding for this research was provided by:
Roche
Article History
First Online: 9 October 2023
Competing interests
: L.S. has conducted consultancy and given lectures for F. Hoffmann-La Roche Ltd, Sarepta Therapeutics, Santhera Pharmaceuticals, Pfizer, Dyne, RegenexBio and SYSNAV. D.E. is an employee of SYSNAV. M.G. is a former employee of SYSNAV. F.M. has conducted consultancies and given lectures for F. Hoffmann-La Roche Ltd, Sarepta Therapeutics, Santhera Pharmaceuticals, Eli Lilly and Company, Pfizer, Wave Life Sciences Ltd, PTC Therapeutics and Dyne Therapeutics. P.S. is an employee of and holds stock in F. Hoffmann-La Roche Ltd. M.A. is an employee of SYSNAV. M.P. declares no conflicts of interest.